Coronary Artery Disease, Percutaneous Coronary Intervention
Conditions
Brief summary
Coronary artery disease is the most important cause of death worldwide. Treatment option for coronary artery disease is medical treatment, percutaneous coronary intervention, or coronary artery bypass surgery. Among them, the field of percutaneous coronary intervention is rapidly developing with regard to the improvement of devices, techniques, or medical treatment, leading to reduce mortality or morbidity. Until now, numerous previous studies related to the risk factors of coronary artery disease and the prognosis of patients have been conducted. However, the field of percutaneous coronary intervention is rapidly evolving, and treatment strategies are constantly being updated. Therefore, the current study sought to identify the long-term prognosis and related risk factors of patients with coronary artery disease who underwent percutaneous coronary intervention.
Interventions
PROCEDUREPercutaneous coronary intervention
Percutaneous Coronary Intervention Procedure
Sponsors
Samsung Medical Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* patients who have undergone or are scheduled to undergo coronary angiography and percutaneous coronary intervention.
Exclusion criteria
* patients who did not consent to the research
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Rates of Cardiac death or Target-vessel myocardial infarction | up to 10 years | A composite of cardiac death or target vessel myocardial infarction |
| Rates of Major adverse cardiac and cerebrovascular event | up to 10 years | A composite of all-cause death, myocardial infarction, cerebrovascular accident, or repeat revascularization |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Rates of myocardial infarction | up to 10 years | Any myocardial infarction |
| Rates of target-vessel myocardial infarction | up to 10 years | target-vessel myocardial infarction |
| Rates of target lesion revascularization | up to 10 years | target lesion revascularization |
| Rates of all-cause death | up to 10 years | Death from any cause |
| Rates of cerebrovascular accident | up to 10 years | ischemic or hemorrhagic stroke |
| Rates of stent thrombosis | up to 10 years | definite or probable stent thrombosis |
| Rates of target vessel revascularization | up to 10 years | target vessel revascularization |
| Rates of cardiac death | up to 10 years | Death from cardiac cause |
Countries
South Korea
Contacts
Primary ContactJoo-Yong Hahn, MD
Backup ContactKi Hong Choi, MD
Outcome results
None listed